Keywords: barr, seasonale, gets, approval, fda, food, drug
Barr's Seasonale gets approval from FDA
Article | 15 September 2003
The US Food and Drug Administration has granted marketing authorization for Barr Laboratories' Seasonale (0.15mg levonorgestrel/0.03mg ethinyl estradiol) as ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
